Novo Starts Sale of Weight-Loss Drug Wegovy in Obesity-Hit India

Injection pens for the weight-loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in Mumbai, India, on Tuesday, June 24, 2025. Novo Nordisk said it will sell its blockbuster weight-loss treatment Wegovy in India starting at $50 a week, tailoring the price to match the pocket of consumers in a nation with the world's third-largest obese population. Photographer: Dhiraj Singh/Bloomberg via Getty Images

Novo Starts Sale of Weight-Loss Drug Wegovy in Obesity-Hit India
Injection pens for the weight-loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in Mumbai, India, on Tuesday, June 24, 2025. Novo Nordisk said it will sell its blockbuster weight-loss treatment Wegovy in India starting at $50 a week, tailoring the price to match the pocket of consumers in a nation with the world's third-largest obese population. Photographer: Dhiraj Singh/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesNovo Starts Sale of Weight-Loss Drug Wegovy in Obesity-Hit India, News PhotoNovo Starts Sale of Weight-Loss Drug Wegovy in Obesity-Hit India, News PhotoNovo Starts Sale of Weight-Loss Drug Wegovy in Obesity-Hit India Get premium, high resolution news photos at Getty ImagesProduct #:2221165529
$499$175
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
2221165529
Collection:
Bloomberg
Date created:
June 24, 2025
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
INDIA WEGOVY
Max file size:
4000 x 2667 px (13.33 x 8.89 in) - 300 dpi - 2 MB